We coordinate

Clinical Trial
National Centre

providing a consistent national approach for commissioners of studies
and offering a comprehensive and targeted service.

Clinical Trial National Centre

or CTNC, provides research, methodological, technical and operational support for clinical research projects. CTNC’s team of experts offers both comprehensive and targeted services – from expert consultation to training – that facilitate the implementation of clinical trials and clinical research projects involving pharmaceuticals, diagnostic methods and medical devices. All activities are carried out in accordance with applicable EU and Czech legislation and Good Clinical Practice (GCP) principles.

National Clinical Trials Centre (CTNC) methodologically manages and coordinates Local CT HUBs (CTUs)which directly support the implementation of clinical trials in all 18 teaching hospitals. It also acts as a central national contact point for all those who wish to conduct clinical research in the Czech Republic. It provides a one-stop-shop service designed to support the rapid, efficient and high-quality implementation of research projects.

Services provided

Commissioning and project management of the study

Preparation of study documentation

Medical writer and consultant

Processing the study with the regulatory authority

Processing of the study by the ethics committee

pharmacovigilance

monitoring

Local CT HUBs

is a network of clinical sites collaborating on non-commercial clinical trials, which currently includes 18 institutions in the Czech Republic.

Local CTU HUBs (CTU) are involved in the planning and implementation of non-commercial clinical trials. It provides activities related to direct access to patients (trial subjects) – ensuring optimal recruitment of subjects for clinical trials. It also participates in the solution of specific activities of clinical trials projects implemented with the support of VVI CZECRIN through the Clinical Research Coordinator, thus fulfilling the basic need for researchers in the Czech Republic.

Clinical trials

non-commercial type form an important part of clinical research in the Czech Republic. Thanks to the CZECRIN infrastructure and the network of Local CTU HUBs, research teams from different healthcare institutions can systematically collaborate, share expertise and conduct clinical trials according to international standards.

Below, you will find an overview of studies that have been created or are ongoing with the support of our infrastructure – from protocol development and regulatory documentation to patient recruitment, center coordination and quality management. For each study, we list its field, phase, design type, and current status so that you can easily get an overview of its progress.

The Ministry of Health unveiled the first National Strategy for Clinical Trials. CZECRIN also contributed to its development.

On July 15, 2026, the Ministry of Health of the Czech Republic presented the first National Strategy for Clinical Trials of Human Medicinal Products in the Czech Republic 2035. The document establishes a long-term framework for the development of clinical research,...

CREATIC has obtained the first hospital exemption for a modern therapy medicinal product in the Czech Republic.

This is a momentous occasion for modern Czech medicine and for patients who find themselves in a situation where standard treatment options are insufficient. A hospital exemption is a tool that allows, under strictly controlled conditions, an unregistered advanced...
tisková konference 2026

Clinical Trials in the Czech Republic: An Investment in Patients, Medicine, and the Future of Healthcare

There are currently 486 clinical trials underway in the Czech Republic, involving more than 2,300 research teams. In 2025 alone, these trials gave 17,451 patients access to innovative treatments—often several years before they would have been normally available. The...

The CREATIC Summer Breakfast Presented the Latest Research Findings and New Options for Undiagnosed Patients

In June, the CREATIC Center of Excellence hosted another edition of its “CREATIC Breakfast,” a regular informal gathering that brings together colleagues from across the center. This format is more than just a morning get-together—it creates a space for discussion,...
Annual meeting 2026

CREATIC Annual Meeting 2026: Moving Forward Together into the Next Phase of the Center’s Development

The CREATIC consortium’s annual meeting took place in Copenhagen on May 27–29, 2026. The three-day program provided partners with an opportunity to assess the project’s progress to date, discuss the outcomes of the most recent Review Meeting, and align priorities for...

Academic research is paving the way for children with cancer to receive modern treatment.

Academic research is paving the way for children with cancer to receive modern treatment. The Czech Republic is strengthening its role in European clinical research. Press Release – [Download the press release as a PDF] Prague, May 20, 2026 — The development of new...

Behind every new treatment is a clinical trial. And behind many of them is CZECRIN.

Behind every drug that becomes part of modern medicine is a long and carefully controlled journey. Before a new treatment enters routine clinical practice, it must be validated in a clinical trial, in an environment where science, clinical experience and patient...

EUPATI – A Path Toward Collaboration Among Patients, Researchers, Regulatory Experts, and Pharmaceutical Companies

What is EUPATI? The European Patients’ Academy for Therapeutic Innovation (EUPATI) is a unique pan-European educational initiative established as a partnership between the public and private sectors and other stakeholders. Its main goal is to provide patients and...

A Turning Point in Modern Medicine: Psychedelics Enter Clinical Practice

Starting on the 1st 1. As of 2026, psychedelic substances may be used for medical purposes in the Czech Republic.This step is the result of long-term, systematic scientific and clinical work based on solid data, an emphasis on patient safety, and a responsible...

Happy New Year 2026

As we enter the new year, we wish everyone involved in clinical research, above all, good health, stability, and favorable working conditions that improve patient care.Thank you for a year together filled with projects, the sharing of expertise, and the strengthening...